More Progress for Bladder-Sparing Strategies in Muscle-Invasive Cancer

(MedPage Today) -- SAN FRANCISCO -- Neoadjuvant chemoimmunotherapy for muscle-invasive bladder cancer (MIBC) followed by risk-adapted therapy led to high rates of metastasis-free survival (MFS) and bladder preservation, according to interim results...